EUVIMEDEUVIMED entdecken
Open Access

Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway

Zafer Usta iD, Şakir Pekgöz iD, Melda Şahin iD, Yağmur Kara iD, Özlem Özmen iD

Journal of Applied Toxicology · 2026

DOI: 10.1002/jat.70097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Zafer Usta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey. Hauptthemen laut MEDLINE: Methotrexate, Apoptosis, Proto-Oncogene Proteins c-bcl-2, bcl-2-Associated X Protein. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Süleyman Demirel University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX)‐induced pulmonary toxicity severely limits its clinical use and effective preventive strategies are lacking. This study evaluated the protective effects of agomelatine (AGO), a melatonergic antidepressant, against MTX‐induced lung injury, focusing on its dual‐pathway action targeting both immune cell infiltration and apoptotic signaling. Thirty‐two female Wistar rats were assigned to: Control, AGO (20 mg/kg/day, p.o., 7 days), MTX (single i.p. dose, 20 mg/kg), and MTX + AGO groups. Lung tissues were examined by histopathology, immunohistochemistry (CD45 + , CD68 + ), and RT‐qPCR (BAX, BCL2). MTX administration caused marked pulmonary damage (histopathological score: 2.75 ± 0.25, p < 0.001), significant infiltration of CD45 + leukocytes and CD68 + macrophages and an elevated BAX/BCL2 ratio (3.5 ± 0.4 vs. 1.0 ± 0.2 in Control, p < 0.001). AGO cotreatment significantly ameliorated these alterations via its dual activity, lowering the histopathological score (1.25 ± 0.25, p < 0.01), reducing CD45 + /CD68 immunopositivity, and restoring the BAX/BCL2 ratio toward cell survival (1.4 ± 0.3, p < 0.01 vs. MTX). These findings provide integrated immunohistochemical and molecular evidence supporting the concurrent modulation of immune cell infiltration and apoptotic signaling by AGO in MTX‐induced lung injury. Given its established clinical use and favorable safety profile, AGO may represent a potential adjunctive candidate to reduce the risk of MTX‐related pulmonary complications, through concurrent targeting of immune and apoptotic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateApoptosisProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinLung InjuryAcetamidesAnimalsFemaleNaphthalenesLeukocyte Common AntigensRats, WistarCD68 MoleculeAntigens, CDAntigens, Differentiation, MyelomonocyticLungSignal TransductionRats

Stichwörter der Autor:innen

agomelatineapoptosisinflammationmethotrexatepulmonary toxicity

Substanzen

MethotrexateNaphthalenesProto-Oncogene Proteins c-bcl-2Leukocyte Common Antigensbcl-2-Associated X ProteinagomelatineCD68 MoleculeAcetamidesAntigens, CDCD68 protein, rat

Autor:innen und Institutionen

  • Department of Genetics, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
  • Department of Medical Services and Techniques, Isparta Vocational School of Health Services, Süleyman Demirel University, Isparta, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
  • Department of Anaesthesiology and Reanimation, Division of Critical Care Medicine, Isparta City Hospital, Isparta, Turkey.

ORCID-Profile: Zafer Usta, Şakir Pekgöz, Melda Şahin, Yağmur Kara, Özlem Özmen

Förderung

  • Süleyman Demirel University Scientific Research Projects Coordination Unit

Zitieren

APA

Usta, Z., Pekgöz, Ş., Şahin, M., Kara, Y., & Özmen, Ö. (2026). Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70097

Vancouver

Usta Z, Pekgöz Ş, Şahin M, Kara Y, Özmen Ö. Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70097

BibTeX
@article{Usta2026,
  author = {Usta, Zafer and Pekgöz, Şakir and Şahin, Melda and Kara, Yağmur and Özmen, Özlem},
  title = {Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  doi = {10.1002/jat.70097}
}
Kostenlos starten →